JP2012510794A5 - - Google Patents

Download PDF

Info

Publication number
JP2012510794A5
JP2012510794A5 JP2011524084A JP2011524084A JP2012510794A5 JP 2012510794 A5 JP2012510794 A5 JP 2012510794A5 JP 2011524084 A JP2011524084 A JP 2011524084A JP 2011524084 A JP2011524084 A JP 2011524084A JP 2012510794 A5 JP2012510794 A5 JP 2012510794A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
group
ctl
apc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011524084A
Other languages
English (en)
Japanese (ja)
Other versions
JP5764823B2 (ja
JP2012510794A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2009/006573 external-priority patent/WO2010064430A1/en
Publication of JP2012510794A publication Critical patent/JP2012510794A/ja
Publication of JP2012510794A5 publication Critical patent/JP2012510794A5/ja
Application granted granted Critical
Publication of JP5764823B2 publication Critical patent/JP5764823B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011524084A 2008-12-05 2009-12-03 Wdrpuhエピトープペプチドおよびそれを含むワクチン Active JP5764823B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20096208P 2008-12-05 2008-12-05
US61/200,962 2008-12-05
US20970409P 2009-03-09 2009-03-09
US61/209,704 2009-03-09
PCT/JP2009/006573 WO2010064430A1 (en) 2008-12-05 2009-12-03 Wdrpuh epitope peptides and vaccines containing the same

Publications (3)

Publication Number Publication Date
JP2012510794A JP2012510794A (ja) 2012-05-17
JP2012510794A5 true JP2012510794A5 (cg-RX-API-DMAC7.html) 2013-01-24
JP5764823B2 JP5764823B2 (ja) 2015-08-19

Family

ID=42233088

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011524084A Active JP5764823B2 (ja) 2008-12-05 2009-12-03 Wdrpuhエピトープペプチドおよびそれを含むワクチン

Country Status (18)

Country Link
US (3) US8541546B2 (cg-RX-API-DMAC7.html)
EP (3) EP2370454A4 (cg-RX-API-DMAC7.html)
JP (1) JP5764823B2 (cg-RX-API-DMAC7.html)
KR (1) KR101705102B1 (cg-RX-API-DMAC7.html)
CN (2) CN102307891B (cg-RX-API-DMAC7.html)
AU (1) AU2009323523B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0922844A2 (cg-RX-API-DMAC7.html)
CA (2) CA3031126C (cg-RX-API-DMAC7.html)
DK (1) DK3219720T3 (cg-RX-API-DMAC7.html)
ES (1) ES2913148T3 (cg-RX-API-DMAC7.html)
IL (2) IL212945B (cg-RX-API-DMAC7.html)
MX (1) MX2011005944A (cg-RX-API-DMAC7.html)
NZ (2) NZ593086A (cg-RX-API-DMAC7.html)
RU (1) RU2514386C2 (cg-RX-API-DMAC7.html)
SG (1) SG171977A1 (cg-RX-API-DMAC7.html)
TW (2) TWI539160B (cg-RX-API-DMAC7.html)
WO (1) WO2010064430A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201104890B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140138900A (ko) 2012-03-09 2014-12-04 온코세라피 사이언스 가부시키가이샤 펩티드를 포함한 의약 조성물
JP6283861B2 (ja) 2012-09-11 2018-02-28 オンコセラピー・サイエンス株式会社 Ube2tペプチドおよびそれを含むワクチン

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
EP0841945B1 (en) 1995-08-03 2006-03-08 Rijksuniversiteit te Leiden Cell derived antigen presenting vesicles
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
JP2000516090A (ja) 1996-07-26 2000-12-05 スローン―ケッタリング インスティチュート フォー キャンサー リサーチ 遺伝子的免疫化のための方法と試薬
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
AU749544B2 (en) 1998-06-25 2002-06-27 Dainippon Sumitomo Pharma Co., Ltd. Tumor antigen peptides originating in cyclophilin B
CN101613406A (zh) 2002-06-06 2009-12-30 肿瘤疗法科学股份有限公司 与人结肠癌相关的基因和多肽
WO2003104275A2 (en) 2002-06-06 2003-12-18 Oncotherapy Science, Inc. Genes and polypeptides relating to human colon cancers
EP2267023B1 (en) * 2002-09-12 2015-02-11 Oncotherapy Science, Inc. KDR peptides and vaccines comprising the same
WO2006031221A1 (en) 2004-09-13 2006-03-23 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Compositions comprising t cell receptors and methods of use thereof
DK2325306T3 (en) 2005-02-25 2014-03-03 Oncotherapy Science Inc Peptide vaccines against lung cancers expressing TTK, URLC10 or KOC1 polypeptide
CN101287831B (zh) 2005-09-13 2013-05-15 国立大学法人三重大学 T细胞受体和编码该受体的核酸
TWI494319B (zh) * 2007-02-21 2015-08-01 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201425333A (zh) * 2007-04-11 2014-07-01 Oncotherapy Science Inc 腫瘤血管內皮標誌8胜肽及包含此胜肽之疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Similar Documents

Publication Publication Date Title
JP2012500001A5 (cg-RX-API-DMAC7.html)
JP2012517799A5 (cg-RX-API-DMAC7.html)
US11414457B2 (en) Immunogenic WT-1 peptides and methods of use thereof
US20230277641A1 (en) Telomerase polypeptide vaccine for treating cancer
JP2010523471A5 (cg-RX-API-DMAC7.html)
JP2011524737A5 (cg-RX-API-DMAC7.html)
Fifis et al. Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice
RU2009141595A (ru) Пептиды тем8 и содержащие их вакцины
RU2011138160A (ru) Пептиды foxmi и вакцины, содержащие их
JP2008530975A5 (cg-RX-API-DMAC7.html)
RU2012127358A (ru) Олигопептиды imp-3 и содержащие их вакцины
RU2011101709A (ru) Cdca1 эпитоп-пептиды и содержащие их вакцины
JPWO2003028757A1 (ja) 抗原特異的t細胞の新規な誘導方法
JP2013511958A5 (cg-RX-API-DMAC7.html)
RU2010154081A (ru) Эпитопные пептиды iqgap3 вакцины, содержащие их
JP2011529683A5 (cg-RX-API-DMAC7.html)
JP2013523084A5 (cg-RX-API-DMAC7.html)
RU2010154101A (ru) Пептиды эпитопов mybl2 и содержащие их вакцины
JP2016511221A5 (cg-RX-API-DMAC7.html)
JP2012520659A5 (cg-RX-API-DMAC7.html)
JP2010514669A5 (cg-RX-API-DMAC7.html)
JP2014533095A5 (cg-RX-API-DMAC7.html)
RU2014121502A (ru) Пептиды торк и содержащие их вакцины
JP2013517764A5 (cg-RX-API-DMAC7.html)
JP2015529219A5 (cg-RX-API-DMAC7.html)